The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Zabel, Brian A ^a   Lewén, Susanna ^a   Berahovich, Robert D ^a   Jaén, Juan C ^a   Schall, Thomas J ^a  

^a ChemoCentryx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR7; PLERIXAFOR; ANTIBODY; ANTINEOPLASTIC AGENT; CHEMOKINE; CHEMOKINE RECEPTOR CXCR; CXCR5 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; BURKITT LYMPHOMA; CANCER CELL; CANCER INVASION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; B CELL LYMPHOMA; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR CELL LINE;

ANTIBODIES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; LYMPHOMA, B-CELL; NEOPLASMS; RECEPTORS, CCR7; RECEPTORS, CXCR; RECEPTORS, CXCR5; RNA, SMALL INTERFERING; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 79958269508     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-73     Document Type: Article

References (33)

1. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol 2008, 214:283-293. 10.1002/path.2282, 18095256.
2. Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol 2004, 14:181-185. 10.1016/j.semcancer.2003.10.004, 15246053.
3. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008, 25:345-356. 10.1007/s10585-007-9097-3, 17891505.
4. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007, 292:C987-995.
5. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman RS, Pienta KJ, Wang J. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 2010, 29:709-722. 10.1007/s10555-010-9256-x, 20839032.
6. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 2006, 13:191-199.
7. Costa V, Sommese L, Casamassimi A, Colicchio R, Angelini C, Marchesano V, Milone L, Farzati B, Giovane A, Fiorito C, Rienzo M, Picardi M, Avallone B, Marco M, Sarubbi B, Calabrò R, Salvatore P, Ciccodicola A, Napoli C. Impairment of circulating endothelial progenitors in Down syndrome. BMC Med Genomics 2010, 3:40-52. 10.1186/1755-8794-3-40, 2949777, 20836844.
8. Hassan S, Baccarelli A, Salvucci O, Basik M. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 2008, 14:446-454. 10.1158/1078-0432.CCR-07-1189, 18223219.
9. Kirkpatrick B, Nguyen L, Kondrikova G, Herberg S, Hill WD. Stability of human stromal-derived factor-1alpha (CXCL12alpha) after blood sampling. Ann Clin Lab Sci 2010, 40:257-260.
10. Roodhart JM, Langenberg MH, Vermaat JS, Lolkema MP, Baars A, Giles RH, Witteveen EO, Voest EE. Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients. Neoplasia 2010, 12:87-94. 2805887, 20072657.
11. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M, Cyster JG. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002, 169:424-433.
12. Airoldi I, Cocco C, Morandi F, Prigione I, Pistoia V. CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow. Cancer Immunol Immunother 2008, 57:541-548. 10.1007/s00262-007-0392-2, 17786442.
13. Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007, 110:3316-3325. 10.1182/blood-2007-05-089409, 17652619.
14. Capriotti E, Vonderheid EC, Thoburn CJ, Bright EC, Hess AD. Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. J Invest Dermatol 2007, 127:2882-2892. 10.1038/sj.jid.5700916, 17597825.
15. López-Giral S, Quintana NE, Cabrerizo M, Alfonso-Pérez M, Sala-Valdés M, De Soria VG, Fernández-Rañada JM, Fernández-Ruiz E, Muñoz C. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 2004, 76:462-471. 10.1189/jlb.1203652, 15155773.
16. Bai Z, Hayasaka H, Kobayashi M, Li W, Guo Z, Jang MH, Kondo A, Choi BI, Iwakura Y, Miyasaka M. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J Immunol 2009, 182:1287-1295.
17. Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, Cyster JG. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002, 196:65-75. 10.1084/jem.20020201, 2194009, 12093871.
18. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006, 203:2201-2213. 10.1084/jem.20052144, 2118398, 16940167.
19. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007, 104:15735-15740. 10.1073/pnas.0610444104, 1994579, 17898181.
20. Gross N, Meier R. Chemokines in neuroectodermal cancers: the crucial growth signal from the soil. Semin Cancer Biol 2009, 19:103-110. 10.1016/j.semcancer.2008.10.009, 19015030.
21. Hattermann K, Held-Feindt J, Lucius R, Müerköster SS, Penfold ME, Schall TJ, Mentlein R. The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects. Cancer Res 2010, 70:3299-3308. 10.1158/0008-5472.CAN-09-3642, 20388803.
22. Zheng K, Li HY, Su XL, Wang XY, Tian T, Li F, Ren GS. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2010, 29:31-44. 10.1186/1756-9966-29-31, 2859378, 20380740.
23. Maréchal R, Demetter P, Nagy N, Berton A, Decaestecker C, Polus M, Closset J, Devière J, Salmon I, Van Laethem JL. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer 2009, 100:1444-1451. 10.1038/sj.bjc.6605020, 2694427, 19352387.
24. Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H, Miyahara R. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer 2009, 115:2580-2593. 10.1002/cncr.24281, 19309748.
25. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008, 283:4283-4294.
26. Schutyser E, Su Y, Yu Y, Gouwy M, Zaja-Milatovic S, Van Damme J, Richmond A. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 2007, 18:59-70. 2665278, 17594938.
27. Izraely S, Klein A, Sagi-Assif O, Meshel T, Tsarfaty G, Hoon DS, Witz IP. Chemokine-chemokine receptor axes in melanoma brain metastasis. Immunol Lett 2010, 130:107-114. 10.1016/j.imlet.2009.12.003, 20005902.
28. Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, Ratajczak J, Kucia M, Ratajczak MZ. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 2010, 127:2554-2268. 10.1002/ijc.25245, 20162608.
29. Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A, Milanesi I, Silvani A, DiMeco F, Carbone A, Pollo B. CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol Ther 2009, 8:1608-1614. 10.4161/cbt.8.17.9202, 19625779.
30. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili A, Janowska-Wieczorek A, Jaen JC, Schall TJ. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell trans-endothelial migration by CXCR7 ligands. J Immunol 2009, 183:3204-3211. 10.4049/jimmunol.0900269, 19641136.
31. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004, 14:171-179. 10.1016/j.semcancer.2003.10.003, 15246052.
32. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004, 64:8604-8612. 10.1158/0008-5472.CAN-04-1844, 15574767.
33. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 2008, 122:91-99. 10.1002/ijc.23083, 17893878.